These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15807846)

  • 1. A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1).
    Repik A; Pincus SE; Ghiran I; Nicholson-Weller A; Asher DR; Cerny AM; Casey LS; Jones SM; Jones SN; Mohamed N; Klickstein LB; Spitalny G; Finberg RW
    Clin Exp Immunol; 2005 May; 140(2):230-40. PubMed ID: 15807846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model.
    Taylor RP; Sutherland WM; Martin EN; Ferguson PJ; Reinagel ML; Gilbert E; Lopez K; Incardona NL; Ochs HD
    J Immunol; 1997 Jan; 158(2):842-50. PubMed ID: 8993002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of blood-borne pathogens mediated through bispecific monoclonal antibodies bound to the primate erythrocyte complement receptor.
    Taylor RP; Nardin A; Sutherland WM
    Cancer Immunol Immunother; 1997; 45(3-4):152-5. PubMed ID: 9435861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prototype pathogen bound ex vivo to human erythrocyte complement receptor 1 via bispecific monoclonal antibody complexes is cleared to the liver in a mouse model.
    Nardin A; Schlimgen R; Holers VM; Taylor RP
    Eur J Immunol; 1999 May; 29(5):1581-6. PubMed ID: 10359112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys.
    Reist CJ; Liang HY; Denny D; Martin EN; Scheld WM; Taylor RP
    Eur J Immunol; 1994 Sep; 24(9):2018-25. PubMed ID: 8088321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
    Sharma R; Zhao H; Al-Saleem FH; Ubaid AS; Puligedda RD; Segan AT; Lindorfer MA; Bermudez R; Elias M; Adekar SP; Simpson LL; Taylor RP; Dessain SK
    Mol Immunol; 2014 Feb; 57(2):247-54. PubMed ID: 24184879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.
    Henderson AL; Lindorfer MA; Kennedy AD; Foley PL; Taylor RP
    J Immunol Methods; 2002 Dec; 270(2):183-97. PubMed ID: 12379324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primate erythrocyte (E) complement receptor (CR1) as an anchor site for bispecific-based therapies to clear pathogens or autoantibodies safely from the circulation.
    Taylor RP; Ferguson PJ
    J Hematother; 1995 Oct; 4(5):357-62. PubMed ID: 8581369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model.
    Taylor RP; Martin EN; Reinagel ML; Nardin A; Craig M; Choice Q; Schlimgen R; Greenbaum S; Incardona NL; Ochs HD
    J Immunol; 1997 Oct; 159(8):4035-44. PubMed ID: 9378993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer of immune complexes from erythrocyte CR1 to mouse macrophages.
    Reinagel ML; Taylor RP
    J Immunol; 2000 Feb; 164(4):1977-85. PubMed ID: 10657648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigens pre-bound to the primate erythrocyte complement receptor via cross-linked bispecific monoclonal antibody heteropolymers are rapidly cleared from the circulation.
    Reist CJ; Combs MJ; Croft BY; Taylor RP
    Eur J Immunol; 1993 Nov; 23(11):3021-7. PubMed ID: 8223879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heteropolymers: a novel technology against blood-borne infections.
    Mohamed N; Jones SM; Casey LS; Pincus SE; Spitalny GL
    Curr Opin Mol Ther; 2005 Apr; 7(2):144-50. PubMed ID: 15844622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence.
    Li J; Wang JP; Ghiran I; Cerny A; Szalai AJ; Briles DE; Finberg RW
    Infect Immun; 2010 Jul; 78(7):3129-35. PubMed ID: 20439480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications.
    Lindorfer MA; Hahn CS; Foley PL; Taylor RP
    Immunol Rev; 2001 Oct; 183():10-24. PubMed ID: 11782244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model.
    Kuhn SE; Nardin A; Klebba PE; Taylor RP
    J Immunol; 1998 May; 160(10):5088-97. PubMed ID: 9590260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of bispecific monoclonal antibody complexes into monkeys provides immunologic protection against later challenge with a model pathogen.
    Craig ML; Reinagel ML; Martin EN; Schlimgen R; Nardin A; Taylor RP
    Clin Immunol; 1999 Aug; 92(2):170-80. PubMed ID: 10444361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus bound to complement receptor 1 on human erythrocytes by bispecific monoclonal antibodies is phagocytosed by acceptor macrophages.
    Gyimesi E; Bankovich AJ; Schuman TA; Goldberg JB; Lindorfer MA; Taylor RP
    Immunol Lett; 2004 Sep; 95(2):185-92. PubMed ID: 15388259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA; Ng YC; Paccaud JP; Walport MJ
    Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.